TranS1 Reports 32% Fall in 3Q Revenues

TranS1 has reported third-quarter revenues of $3.2 million, a 32 percent decreased compared to the same period last year.

Advertisement

The spine device company also saw declines in domestic revenues and gross margin and an increase in net losses.

More Articles on Orthopedic Devices:

DePuy Launches New Trumatch Pin for Orthopedic Implants

Investors Increase Stake in Smith & Nephew

Titan Spine Appoints Marcus Klarl Vice President of Sales

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.